Global Blood DNA Kit Market Growth 2024-2030
A Blood DNA Kit typically refers to a kit used for the extraction and purification of DNA from blood samples. These kits are designed to efficiently isolate DNA from various types of blood samples, including whole blood or blood components such as buffy coat or plasma.
The global Blood DNA Kit market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Blood DNA Kit Industry Forecast” looks at past sales and reviews total world Blood DNA Kit sales in 2023, providing a comprehensive analysis by region and market sector of projected Blood DNA Kit sales for 2024 through 2030. With Blood DNA Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood DNA Kit industry.
This Insight Report provides a comprehensive analysis of the global Blood DNA Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood DNA Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood DNA Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood DNA Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood DNA Kit.
United States market for Blood DNA Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Blood DNA Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Blood DNA Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Blood DNA Kit players cover QIAGEN, Thermo Fisher Scientific, Sigma-Aldrich (Merck), Roche, Axygen (Corning), etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood DNA Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Whole Blood
Plasma or Serum
Buffy Coat
Segmentation by Application:
R&D Organisations
Biotechnology Companies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
QIAGEN
Thermo Fisher Scientific
Sigma-Aldrich (Merck)
Roche
Axygen (Corning)
Analytik Jena
Promega
Zymo Research
Illumina
Macherey-Nagel
Bio-Rad
Omega Bio-tek
Geneaid
Lucigen (Biosearch Technologies)
Norgen
MGI Tech Co., Ltd.
BioVision
Key Questions Addressed in this Report
What is the 10-year outlook for the global Blood DNA Kit market?
What factors are driving Blood DNA Kit market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Blood DNA Kit market opportunities vary by end market size?
How does Blood DNA Kit break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.